Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2007

01-01-2007 | Case Report

Intraductal Papillary Mucinous Neoplasm Associated with Incomplete Pancreas Divisum as a Cause of Acute Recurrent Pancreatitis

Authors: Mark J. Sterling, Samuel N. Giordano, Alireza Sedarat, Kenneth Belitsis

Published in: Digestive Diseases and Sciences | Issue 1/2007

Login to get access

Excerpt

Intraductal papillary mucinous neoplasm (IPMN) was thought to be a rare neoplasm of the exocrine pancreas, with an estimated incidence of 1 in 281,000 patients per year [1]. It is characterized by mucin production, intraductal papillary growth, and cystic dilation of the pancreatic ducts. This entity has been increasingly detected and reported in the literature recently, likely due to progress in imaging and endoscopic evaluation of the pancreas. An increase in the incidence of IPMN has also been suggested [2]. IPMN of the minor duct is rare, and only a few mucin-producing tumors have been reported associated with pancreas divisum [35]. Pancreas divisum is a common congenital anomaly of the pancreas and thought to occur in approximately 10% of patients in the United States [6]. We report the first known case in the literature of IPMN affecting the minor ampulla and associated with incomplete pancreas divisum. Interestingly, in every case except one, IPMN associated with pancreas divisum mainly affected the dorsal ductal (minor) system [7]. Our patient also demonstrates the diagnostic difficulties that are present in the evaluation of IPMN, in particular, the additional complicating factors in patients with pancreas divisum and acute recurrent pancreatitis. …
Literature
1.
go back to reference McDonald JM, Willard W, Mais D, Beitler A (2000) The incidence of intraductal papillary mucinous tumors of the pancreas. Curr Surg 57:610–614PubMedCrossRef McDonald JM, Willard W, Mais D, Beitler A (2000) The incidence of intraductal papillary mucinous tumors of the pancreas. Curr Surg 57:610–614PubMedCrossRef
2.
go back to reference Sohn TA, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH, Lillemoe KD (2001) Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 234:313–322PubMedCrossRef Sohn TA, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH, Lillemoe KD (2001) Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 234:313–322PubMedCrossRef
3.
go back to reference Origuchi N, Kimura W, Muto T, Esaki Y (1996) Mucin-producing adenoma associated with pancreas divisum and hepatic hilar carcinoma: an autopsy case. J Gastroenterol 31(3):455–459PubMedCrossRef Origuchi N, Kimura W, Muto T, Esaki Y (1996) Mucin-producing adenoma associated with pancreas divisum and hepatic hilar carcinoma: an autopsy case. J Gastroenterol 31(3):455–459PubMedCrossRef
4.
go back to reference Yarze JC, Chase MP, Herlihy KJ, Nawras A (2003) Pancreas divisum and intraductal papillary mucinous tumor occurring simultanously in a patient presenting with recurrent acute pancreatitis. Dig Dise Sci 48(5):915CrossRef Yarze JC, Chase MP, Herlihy KJ, Nawras A (2003) Pancreas divisum and intraductal papillary mucinous tumor occurring simultanously in a patient presenting with recurrent acute pancreatitis. Dig Dise Sci 48(5):915CrossRef
5.
go back to reference Sakurai Y, Matsubara T, Imazu H, Hasegawa S, Miyakawa S, Ochiai M, Funabiki T, Mizoguchi Y, Kuroda M (2004) Intraductal papillary-mucinous tumor of the pancreas head with complete absence of the ventral pancreatic duct of Wirsung. J Hepato-Biliary-Pancreat Surg 11(4):293298 Sakurai Y, Matsubara T, Imazu H, Hasegawa S, Miyakawa S, Ochiai M, Funabiki T, Mizoguchi Y, Kuroda M (2004) Intraductal papillary-mucinous tumor of the pancreas head with complete absence of the ventral pancreatic duct of Wirsung. J Hepato-Biliary-Pancreat Surg 11(4):293298
6.
go back to reference Lehman GA, Sherman S (1998) Diagnosis and therapy of pancreas divisum. Gastrointest Endosc Clin N Am 8:55–77PubMed Lehman GA, Sherman S (1998) Diagnosis and therapy of pancreas divisum. Gastrointest Endosc Clin N Am 8:55–77PubMed
7.
go back to reference Sakate Y, Ohira M, Maeda K, Yamada N, Nishihara T, Nakata B, Nishiguchi Y, Nishino H, Hirakawa K (2004) Intraductal papillary-mucinous adenoma developed in the ventral pancreas in a patient with pancreas divisum. J Hepato-Biliary-Pancreat Surg 11(5):366–370CrossRef Sakate Y, Ohira M, Maeda K, Yamada N, Nishihara T, Nakata B, Nishiguchi Y, Nishino H, Hirakawa K (2004) Intraductal papillary-mucinous adenoma developed in the ventral pancreas in a patient with pancreas divisum. J Hepato-Biliary-Pancreat Surg 11(5):366–370CrossRef
8.
go back to reference Okabayashi T, Kobayashi M, Nishimori I, Sugimoto T, Namikawa T, Okamoto K, Okamoto N, Kosaki T, Onishi S, Araki K (2006) J Gastroenterol Hepatol 21(2):462–467PubMedCrossRef Okabayashi T, Kobayashi M, Nishimori I, Sugimoto T, Namikawa T, Okamoto K, Okamoto N, Kosaki T, Onishi S, Araki K (2006) J Gastroenterol Hepatol 21(2):462–467PubMedCrossRef
9.
go back to reference Bassi C, Procacci C, Zamboni G, Scarpa A, Cavallini G, Pederzoli P (2000) Intraductal papillary mucinous tumors of the pancreas. Verona University Pancreatic Team. Int J Pancreatol 27:181–193PubMed Bassi C, Procacci C, Zamboni G, Scarpa A, Cavallini G, Pederzoli P (2000) Intraductal papillary mucinous tumors of the pancreas. Verona University Pancreatic Team. Int J Pancreatol 27:181–193PubMed
10.
go back to reference Farrell JJ, Brugge WR (2002) Intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc 55(6):701–714PubMedCrossRef Farrell JJ, Brugge WR (2002) Intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc 55(6):701–714PubMedCrossRef
11.
go back to reference Kobari M, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, Matsuno S, Furukawa T (1999) Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 134(10):1131–1136PubMedCrossRef Kobari M, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, Matsuno S, Furukawa T (1999) Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 134(10):1131–1136PubMedCrossRef
12.
go back to reference Bernard JP, Sahel J, Giovannini M, Sarles H (1990) Pancreas divisum is a probable cause of acute pancreatitis: a report of 137 cases. Pancreas 5:248–254PubMedCrossRef Bernard JP, Sahel J, Giovannini M, Sarles H (1990) Pancreas divisum is a probable cause of acute pancreatitis: a report of 137 cases. Pancreas 5:248–254PubMedCrossRef
13.
go back to reference Yamaguchi K, Nakamura M, Shirahane K, Kawamoto M, Konomi H, Ohta M, Tanaka M (2005) Pancreatic juice cytology in IPMN of the pancreas. Pancreatology 5(4–5):416–421; discussion 421 (Epub 28 June 2005)PubMedCrossRef Yamaguchi K, Nakamura M, Shirahane K, Kawamoto M, Konomi H, Ohta M, Tanaka M (2005) Pancreatic juice cytology in IPMN of the pancreas. Pancreatology 5(4–5):416–421; discussion 421 (Epub 28 June 2005)PubMedCrossRef
Metadata
Title
Intraductal Papillary Mucinous Neoplasm Associated with Incomplete Pancreas Divisum as a Cause of Acute Recurrent Pancreatitis
Authors
Mark J. Sterling
Samuel N. Giordano
Alireza Sedarat
Kenneth Belitsis
Publication date
01-01-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9543-0

Other articles of this Issue 1/2007

Digestive Diseases and Sciences 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine